Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss

Osteoporosis is a common metabolic bone disease with a rapidly increasing prevalence, characterized by massive bone loss because of excessive osteoclast formation. Gallic acid (GA), a phenolic acid isolated from Cornus officinalis, has anti-inflammatory and anti-oxidant effects, but its effect on os...

Full description

Bibliographic Details
Main Authors: Peng Zhang, Jiekai Ye, Jiale Dai, Ying Wang, Genjun Chen, Jinping Hu, Qimiao Hu, Jun Fei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.963237/full
_version_ 1811291296215597056
author Peng Zhang
Jiekai Ye
Jiale Dai
Ying Wang
Genjun Chen
Jinping Hu
Qimiao Hu
Jun Fei
author_facet Peng Zhang
Jiekai Ye
Jiale Dai
Ying Wang
Genjun Chen
Jinping Hu
Qimiao Hu
Jun Fei
author_sort Peng Zhang
collection DOAJ
description Osteoporosis is a common metabolic bone disease with a rapidly increasing prevalence, characterized by massive bone loss because of excessive osteoclast formation. Gallic acid (GA), a phenolic acid isolated from Cornus officinalis, has anti-inflammatory and anti-oxidant effects, but its effect on osteoclast formation has not been confirmed. In our study, we demonstrated that GA significantly inhibited RANKL‐induced osteoclast formation and function of osteoclast in bone marrow monocytes (BMMs) and RAW264.7 cells in a dose-dependent manner without cytotoxicity. For molecular mechanisms, GA repressed osteoclastogenesis by blocking Akt, ERK, and JNK pathways, and suppressed osteoclastogenesis-related marker expression, including nuclear factor of the activated T-cell cytoplasmic 1 (NFATc1), c‐Fos, and cathepsin K (CTSK). In addition, we further assessed the effect of GA in an ovariectomized mouse model, which indicated that GA has a notable effect on preventing bone loss. In conclusion, GA exerts notable effects in inhibiting osteoclastogenesis and preventing ovariectomy-induced bone loss, suggesting that GA is a potential agent in osteoporosis treatment.
first_indexed 2024-04-13T04:27:16Z
format Article
id doaj.art-e7c9bf5635d34b2dabf6623fa0885413
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T04:27:16Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-e7c9bf5635d34b2dabf6623fa08854132022-12-22T03:02:28ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-12-011310.3389/fendo.2022.963237963237Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone lossPeng Zhang0Jiekai Ye1Jiale Dai2Ying Wang3Genjun Chen4Jinping Hu5Qimiao Hu6Jun Fei7Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaThe Third Clinical College of Zhejiang Chinese Medical University, Hangzhou, ChinaZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaThe Third Clinical College of Zhejiang Chinese Medical University, Hangzhou, ChinaZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, ChinaOsteoporosis is a common metabolic bone disease with a rapidly increasing prevalence, characterized by massive bone loss because of excessive osteoclast formation. Gallic acid (GA), a phenolic acid isolated from Cornus officinalis, has anti-inflammatory and anti-oxidant effects, but its effect on osteoclast formation has not been confirmed. In our study, we demonstrated that GA significantly inhibited RANKL‐induced osteoclast formation and function of osteoclast in bone marrow monocytes (BMMs) and RAW264.7 cells in a dose-dependent manner without cytotoxicity. For molecular mechanisms, GA repressed osteoclastogenesis by blocking Akt, ERK, and JNK pathways, and suppressed osteoclastogenesis-related marker expression, including nuclear factor of the activated T-cell cytoplasmic 1 (NFATc1), c‐Fos, and cathepsin K (CTSK). In addition, we further assessed the effect of GA in an ovariectomized mouse model, which indicated that GA has a notable effect on preventing bone loss. In conclusion, GA exerts notable effects in inhibiting osteoclastogenesis and preventing ovariectomy-induced bone loss, suggesting that GA is a potential agent in osteoporosis treatment.https://www.frontiersin.org/articles/10.3389/fendo.2022.963237/fullosteoclastGallic acidAktERKJNKosteoporosis
spellingShingle Peng Zhang
Jiekai Ye
Jiale Dai
Ying Wang
Genjun Chen
Jinping Hu
Qimiao Hu
Jun Fei
Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
Frontiers in Endocrinology
osteoclast
Gallic acid
Akt
ERK
JNK
osteoporosis
title Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
title_full Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
title_fullStr Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
title_full_unstemmed Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
title_short Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
title_sort gallic acid inhibits osteoclastogenesis and prevents ovariectomy induced bone loss
topic osteoclast
Gallic acid
Akt
ERK
JNK
osteoporosis
url https://www.frontiersin.org/articles/10.3389/fendo.2022.963237/full
work_keys_str_mv AT pengzhang gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT jiekaiye gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT jialedai gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT yingwang gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT genjunchen gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT jinpinghu gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT qimiaohu gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss
AT junfei gallicacidinhibitsosteoclastogenesisandpreventsovariectomyinducedboneloss